Mablink is Biotechnology in France that focus on next-generation Antibody business. Founded in 2018. They cover business area such as developer, next-generation Antibody-Drug-Conjugates, (adc, drug, cancer, its propriety hydrophilic linker platform, approach, implement, next-generation adc.
2018
( 6 years old in 2024 )
Next-generation Antibody
-
Espace Deskeo
69 rue de la République
69002 Lyon
France
Private
developernext-generation Antibody-Drug-Conjugates(adcdrugcancerits propriety hydrophilic linker platformapproachimplementnext-generation adc
* We use standard office opening hours in near Mablink's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mablink is Biotechnology business from France that founded in 2018 (6 years old in 2024), Mablink business is focusing on Next-generation Antibody.
Mablink headquarter office and corporate office address is located in Espace Deskeo 69 rue de la République 69002 Lyon France.
Mablink was founded in France.
In 2024, Mablink is currently focus on next-generation Antibody sector.
Above is snippet of Google Trends for "next-generation Antibody" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mablink, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
